View in EDS

Cardiovascular, Kidney, and Safety Outcomes With GLP-1 Receptor Agonists Alone and in Combination With SGLT2 Inhibitors in Type 2 Diabetes: A Systematic Review and Meta-Analysis.

Saved in:
Bibliographic Details
Title: Cardiovascular, Kidney, and Safety Outcomes With GLP-1 Receptor Agonists Alone and in Combination With SGLT2 Inhibitors in Type 2 Diabetes: A Systematic Review and Meta-Analysis.
Authors: Neuen, Brendon L.1,2 (AUTHOR) bneuen@georgeinstitute.org.au, Fletcher, Robert A.1 (AUTHOR), Heath, Lauren2 (AUTHOR) lauren.heath1@health.nsw.gov.au, Perkovic, Adam2 (AUTHOR) vlado.perkovic@unsw.edu.au, Vaduganathan, Muthiah3,4 (AUTHOR) mvaduganathan@bwh.harvard.edu, Badve, Sunil V.1,5 (AUTHOR), Tuttle, Katherine R.6,7 (AUTHOR) katherine.tuttle@providence.org, Pratley, Richard8 (AUTHOR) Richard.Pratley.MD@AdventHealth.com, Gerstein, Hertzel C.9 (AUTHOR) gerstein@mcmaster.ca, Perkovic, Vlado1,10 (AUTHOR) vlado.perkovic@unsw.edu.au, Heerspink, Hiddo J.L.1,11 (AUTHOR) h.j.lambers.heerspink@umcg.nl
Source: Circulation. 11/26/2024, Vol. 150 Issue 22, p1781-1790. 10p.
Database: Academic Search Ultimate
Description
ISSN:00097322
DOI:10.1161/CIRCULATIONAHA.124.071689